Pharma Industry
Latest News
Advertisement
Latest Videos
Shorts
0:26
Patients give up before the prior auth clears
14 days ago
by
Jay Bregman
0:51
The evidence on ivermectin for cyclosporiasis
a month ago
by
Molly O'Shea, M.D., FAAP
1:12
Why health insurance premiums keep climbing
a month ago
by
Gary Jacobs
0:39
The biggest problem in health care IT
a month ago
by
Joseph Kleiman
0:32
A message to health system administrators
a month ago
by
Joseph Kleiman
0:44
A pharmacy benefit model built to cut prior authorization
2 months ago
by
Jay Bregman
0:59
Is insurance actually the best deal?
2 months ago
by
Joseph Kleiman
1:11
Why GLP-1s broke pharmacy coverage
2 months ago
by
Jay Bregman
0:37
Help for burnt-out doctors
2 months ago
by
Joseph Kleiman
1:13
Medicare and Medicaid's GLP-1 programs: A real split or a distinction without a difference?
2 months ago
by
Tracy Zvenyach, Ph.D., M.S., R.N.
Podcasts
Advertisement
More News
Lowering drug costs for older adults is a laudable goal, but don’t do it by blocking physician access to needed medicines.
Andel is one of a growing number of companies selling brand-name drugs straight to employers, bypassing pharmacy benefit managers and insurers. Medical Economics sat down with founder and CEO Jay Bregman to understand the model and what physicians should keep in mind.
Medication adherence is a persistent challenge in healthcare. Prior auths are making it worse. Can CMS fix the problem?
A practical guide for physicians to improve their medication stewardship.
Because clinicians and the system are not programmed to ask: What can safely be stopped?
There needs to be conversations about pricing and fulfillment options at the point of prescribing, so patients can compare pricing and make an informed decision.
The top news stories in medicine this week.
Did you know that 45% of Americans misread their drug labels?
The top news stories in medicine this week.
Access, affordability, ambiguity: Who really benefits from federal prescription drug price policies?
A policy expert explains what physicians need to know when patients ask about the changing prices of their medicines.
But some of the state’s top physicians and clinicians say they were blindsided by the pilot program.
The top news stories in medicine this week.
When it comes to filling prescriptions, having a nearby pharmacy isn't always enough.
Everyday prescriptions such as atorvastatin, lisinopril and metformin are now on the federal price comparison site, though experts say insured patients still may pay less through their plans.
Here’s how three states used Medicaid policies to cut costs and improve accountability by reining in pharmacy benefit managers
No physician wants to write a prescription that their patient can’t afford. But having affordability information, such as co-pays and vouchers or discounts, embedded into the EHR encourages better conversations between patients and providers about medication costs and support options.
The sad reality is that too many Americans are ingesting a daily cocktail of Big Pharma prescribed by multiple doctors who typically don’t talk to each other or know each other.
Advertisement
Advertisement
Trending on Medical Economics
1
Dolly Parton's health care legacy: Two decades of giving
2
The key tech components every primary care practice needs to deliver exceptional mental health services
3
FDA expands device compatibility for Paradromics' brain-computer interface
4